OVERVIEW
Brain tumors are a heterogenous group of neoplasms with varied management strategies and outcomes. This symposium will present emerging research to help neuro-oncologists better identify relevant molecular markers and appropriate treatment options for subgroups of malignant glioma, and incorporate the latest developments in therapy for patients with high-grade glioma.
TARGET AUDIENCE
This activity is designed for neuro-oncologists, neurosurgeons, radiation oncologists, and other medical oncologists who research, identify, and treat patients with high-grade gliomas. No prerequisites required.
CME INFORMATION
Accreditation Statement — The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation Statement — The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 2 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
After reviewing this interactive case study activity, participants may receive credit by completing the CME test, evaluation, and receiving a score of 70% or higher.
Full Disclosure Policy Affecting CME Activities —As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of the Johns Hopkins University School of Medicine to require the disclosure of the existence of any relevant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The Participating Faculty reported the following:
Alessandro Olivi, MD
Professor of Neurosurgery and Oncology
The Johns Hopkins University School of Medicine
Baltimore, Maryland
Dr Olivi reports having no relevant financial or advisory relationships with corporate organizations related to this activity.
Jaishri Blakeley, MD
Assistant Professor of Neurology, Oncology, and Neurosurgery
The Johns Hopkins University School of Medicine
Baltimore, Maryland
Dr Blakeley reports having no relevant financial or advisory relationships with corporate organizations related to this activity.
Allen K. Sills, MD, FACS
Associate Professor
Department of Neurological Surgery
Vanderbilt University School of Medicine
Nashville, Tennessee
Dr Sills reports having no relevant financial or advisory relationships with corporate organizations related to this activity.
Off-Label Product Discussion
The audience is advised that presentations in this CME activity contain reference(s) to unlabeled or unapproved uses of drugs or devices:
Dr Blakeley—CPT-11, gefitinib, talampanel.
Disclaimer Statement
The opinions and recommendations expressed by faculty and other experts whose input is included in this activity are their own. This activity is produced for educational purposes only. Use of The Johns Hopkins University School of Medicine name implies review of educational format, design, and approach. Please review the complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings, and adverse effects before administering pharmacologic therapy to patients.
Internet CME Policy
The Office of Continuing Medical Education (CME) at The Johns Hopkins University School of Medicine is committed to protect the privacy of its members and customers. The Johns Hopkins University School of Medicine CME maintains its Internet site as an information resource and service for physicians, other health professionals, and the public. Continuing Medical Education at The Johns Hopkins University School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet-based activity. Your information will never be given to anyone outside of The Johns Hopkins University School of Medicine’s CME activity. CME collects only the information necessary to provide you with the services that you request.
Release date: December 15 2009. Expiration date: December 15 2011.
Estimated time to complete activity: 2 hours.
Activity Format: Archived webcast of a symposium held at the official Joint Meeting of the Society for Neuro-Oncology and the AANS/CNS Section on Tumors program.
| Pre-Test
Conference Goals
Alessandro Olivi, MD
Current Controversies in the Management of High-Grade Gliomas: An Interactive Case Discussion
Alessandro Olivi, MD, Allen K. Sills, MD, and Jaishri Blakeley, MD
Cases to be discussed include:
- Biopsy Versus Resection
- Disease Progression and Management of Rapid Transformation
- Can Surgery Improve Quality of Life?
Concluding Remarks
Alessandro Olivi, MD
Post-Test |
|
|
